My Crossword Maker Logo
Powered by BrightSprout
Save Status:
or to save your progress. The page will not refresh.
Controls:
SPACEBAR SWITCHES TYPING DIRECTION
Answer Key:
Edit a Copy:
Make Your Own:
Crucigrama Sopa de Letras Hoja de Trabajo
Calificar este Puzzle:
Log in or sign up to rate this puzzle.

The Cynical Scribe's Guide to the Top Twenty Oncology Labs in the US - USCAP 2023 Edition

Looking for granular intelligence on cancer testing markets in the US and Europe? Contact [email protected] for a Zoom tour of our work.
Horizontales
We're #6 - the lab that defenestrated our CEO in May. Our new CEO is the guy who sold Ortho to Quidel.
We're #8. We're like Levi-Strauss, who thinks they invented jeans. We thought we invented genes until the Supreme Court told us otherwise. It's been a rough ride since then.
We're #15 overall and the #6 NGS lab. Our founding scientist sold the lab for nearly a billion in 2017. Now we are living in a new Realm.
We're #19 - the fastest-growing MRD lab. Our ClonoSEQ volume doubled last year.
We're #18 - the Utah reference lab
We're #16 - the Chicago comprehensive genomic profiling team
We're #17 - the reference lab on Lake Erie
We're #9 - the Walmart of NGS labs. We defenestrated our CEO in July and laid off 1,000 employees. Our new CEO is lucky he took the job just when Illumina's patents were expiring.
G'Day Mate. We're #5 in US oncology testing and the third-largest lab organization on Earth.
Verticales
We're #14. Illumina says we're their biggest customer. We have one of the two biggest NovaSeq fleets in the world.
We're #7 overall but we're #2 in NGS. Illumina says we bit the hand that feeds us, so they sued us last year.
We're #4. We have the top-earning proprietary NGS code. Drug companies drive by our lab and throw bags of cash at our doorstep.
We're #2, after buying PGDx we surpassed our main rival.
We're #13 - the Middle Tennessee lab team. All of our ≈175 pathologists bill AP work under their own name, so you have to look at a hundred little hospitals to figure out how big we are.
We're #10. We weren't near the top twenty before the pandemic. Then we used our covid windfall to buy InformDx and Cytometry Specialists.
We're #3. We do the most anatomic pathology and single-target PCR work, but we're only #11 in NGS
We're #20. We bought Ariosa from Roche in 2021, then sold GeneDx to Sema4 in 2022.
We're #1. We turned stool into 450 bucks 2.8m times last year.
We're #12 - America's favorite academic reference lab. If you visit us in January, dress warm.
We're #10. We took in #115m in 2020 then $285m last year. We love those thyroid FNAs.